XT
BIOA

XTX Topco’s BioAge Labs BIOA Stock Holding History

XTX Topco’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$657K Sell
26,793
-20,085
-43% -$363K 0.01% 2182
2026
Q1 		$820K Buy
46,878
+10,151
+28% +$195K 0.01% 1595
2025
Q4 		$486K Buy
+36,727
New +$326K 0.01% 1627

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

XTX Topco's BIOA Position: Q2 2026 in Review

XTX Topco reduced its BioAge Labs (BIOA) stake by 43% in Q2 2026, selling an estimated $363K and leaving 26,793 shares worth $657K. The position accounts for 0.01% of the portfolio, ranked #2182.

XTX Topco first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. The position peaked at $820K in Q1 2026. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • XTX Topco held 26,793 shares of BioAge Labs worth $657K as of Q2 2026.
  • XTX Topco sold 20,085 BioAge Labs shares in Q2 2026, an estimated $363K.
  • BioAge Labs made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2182 holding.
  • XTX Topco first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • XTX Topco's BioAge Labs position peaked at $820K in Q1 2026.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.